Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Insurers, consumer groups are critical of HHS move on short-term insurance plans

Healthcare advocacy groups and other stakeholders are speaking out against the Trump administration’s decision to allow short-term healthcare insurance plans to extend up to three years.

Thumbnail

Despite regulatory uncertainty, healthcare M&A activity remains constant

More than 200 health services deals were reported in the second quarter of 2018, continuing the ongoing streak of mergers and acquisitions in the sector, according to PricewaterhouseCoopers.

Thumbnail

CMS finalizes $340M payment bump for hospices in 2019

Hospices will see a 1.8 percent, or $340 million, payment increase in 2019 after CMS finalized its annual payment update.

Health insurance marketplace enrollment drops in 1st quarter of 2018

The individual health insurance marketplace experienced a 12 percent decline in enrollment during the first quarter of 2018 compared to the same time period last year.

Thumbnail

‘Medicare for all’ would cost $32.6T over 10 years

Considering healthcare will be a central topic in the run up to the 2018 mid-term elections, “Medicare for all” is a concept that is gaining traction among left-leaning politicians. A recent study, though, found that implementation of such a program would cost $32.6 trillion over 10 years.

Texas hospital co-founder pleads guilty in $200M kickback scheme

Alan Andrew Beauchamp, Dallas-based Forest Park Medical Center’s co-founder and former manager, pleaded guilty in a $200 million healthcare fraud case. Beauchamp recruited high-volume specialty doctors and paid them $40 million in bribes and kickbacks to perform surgeries.

Thumbnail

GSK, 23andMe reach 4-year, $300M deal for sharing of genetic data

GlaxoSmithKline (GSK) announced a four-year, $300 million deal with 23andMe, a personal genomics and biotechnology company based in Mountain View, California. The British pharmaceutical company will have access to genetic information of 23andMe’s five million customers.

Thumbnail

CMS releases plan to streamline Medicare reimbursement

CMS released its plan to reduce paperwork and improve patient care on Friday, July 27, that could have implications for 40 percent of Medicare payments. The plan combines four levels of paperwork and four levels of reimbursement to be combined in a single form and one flat fee for each physician appointment.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup